The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tenalisib, a dual PI3K δ/γ inhibitor: Safety and efficacy results from an on-going phase I/Ib study in relapsed/refractory T-cell lymphoma.
 
Yasuhiro Oki
Employment - Jazz Pharmaceuticals
Honoraria - Takeda
Consulting or Advisory Role - Bristol-Myers Squibb; Meiji Seika Kaisha
 
Bradley Haverkos
No Relationships to Disclose
 
Jasmine M. Zain
Honoraria - celgene; Mallinckrodt; Seagen; Spectrum Pharmaceuticals
Consulting or Advisory Role - celgene; kyocera; Spectrum Pharmaceuticals
Speakers' Bureau - celgene; Mallinckrodt; Seagen; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - Mallinckrodt; Merck; Seagen; Spectrum Pharmaceuticals
 
Mary Jo Lechowicz
No Relationships to Disclose
 
Sumana Devata
Stock and Other Ownership Interests - Abbvie; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novo Nordisk; Pfizer
 
Neil J Korman
No Relationships to Disclose
 
Rod Ramchandren
No Relationships to Disclose
 
Lauren C. Pinter-Brown
No Relationships to Disclose
 
Prajak J. Barde
Employment - Rhizen Pharmaceuticals
 
Ajit Nair
Employment - Rhizen Pharmaceuticals
 
Auris Huen
Consulting or Advisory Role - Kyowa Hakko Kirin; miRagen; Precision Oncology; Seagen; Seagen
Travel, Accommodations, Expenses - Galderma